Analyzing Glucose Health (GLUC) and Its Rivals

Glucose Health (OTCMKTS:GLUC) is one of 51 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its peers? We will compare Glucose Health to similar companies based on the strength of its institutional ownership, profitability, earnings, risk, dividends, valuation and analyst recommendations.

Analyst Ratings

This is a summary of current ratings and price targets for Glucose Health and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glucose Health	0	0	0	0	N/A
Glucose Health Competitors	272	537	978	74	2.46

As a group, “Medicinals & botanicals” companies have a potential upside of 41.95%. Given Glucose Health’s peers higher possible upside, analysts clearly believe Glucose Health has less favorable growth aspects than its peers.

Risk and Volatility

Glucose Health has a beta of 3.49, suggesting that its share price is 249% more volatile than the S&P 500. Comparatively, Glucose Health’s peers have a beta of 1.07, suggesting that their average share price is 7% more volatile than the S&P 500.

Valuation & Earnings

This table compares Glucose Health and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Glucose Health	$540,000.00	-$420,000.00	-5.71
Glucose Health Competitors	$309.39 million	-$49.38 million	-8.42

Glucose Health’s peers have higher revenue, but lower earnings than Glucose Health. Glucose Health is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Glucose Health and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glucose Health	-75.00%	N/A	N/A
Glucose Health Competitors	-42.21%	-22.72%	-7.72%

Institutional and Insider Ownership

15.6% of shares of all “Medicinals & botanicals” companies are owned by institutional investors. 20.9% of shares of all “Medicinals & botanicals” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Glucose Health Company Profile

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.